Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RPRX |
---|---|---|
09:32 ET | 24205 | 26.96 |
09:34 ET | 3526 | 26.92 |
09:36 ET | 1651 | 26.99 |
09:38 ET | 9248 | 27.025 |
09:39 ET | 7100 | 27.005 |
09:41 ET | 1847 | 27.04 |
09:43 ET | 2229 | 27.08 |
09:45 ET | 4761 | 27.071 |
09:48 ET | 2030 | 27.09 |
09:50 ET | 3018 | 27.1 |
09:52 ET | 3466 | 27.12 |
09:54 ET | 5100 | 27.1 |
09:56 ET | 1600 | 27.15 |
09:57 ET | 1023 | 27.17 |
09:59 ET | 5312 | 27.135 |
10:01 ET | 2200 | 27.12 |
10:03 ET | 7294 | 27.19 |
10:06 ET | 5798 | 27.205 |
10:08 ET | 5116 | 27.225 |
10:10 ET | 2700 | 27.275 |
10:12 ET | 6383 | 27.21 |
10:14 ET | 3900 | 27.13 |
10:15 ET | 6002 | 27.16 |
10:17 ET | 4948 | 27.18 |
10:19 ET | 3668 | 27.2 |
10:21 ET | 10914 | 27.2 |
10:24 ET | 4977 | 27.175 |
10:26 ET | 9559 | 27.175 |
10:28 ET | 14378 | 27.2 |
10:30 ET | 946 | 27.23 |
10:32 ET | 5281 | 27.22 |
10:33 ET | 3263 | 27.2 |
10:35 ET | 1137 | 27.185 |
10:37 ET | 2369 | 27.18 |
10:39 ET | 2478 | 27.175 |
10:42 ET | 5052 | 27.14 |
10:44 ET | 2496 | 27.145 |
10:46 ET | 1745 | 27.11 |
10:48 ET | 1500 | 27.12 |
10:50 ET | 2376 | 27.135 |
10:51 ET | 7219 | 27.125 |
10:53 ET | 1100 | 27.14 |
10:55 ET | 4319 | 27.1798 |
10:57 ET | 1115 | 27.185 |
11:00 ET | 1889 | 27.195 |
11:02 ET | 7371 | 27.18 |
11:04 ET | 3228 | 27.1991 |
11:06 ET | 3707 | 27.21 |
11:08 ET | 2169 | 27.23 |
11:09 ET | 2529 | 27.265 |
11:11 ET | 3460 | 27.265 |
11:13 ET | 422 | 27.26 |
11:15 ET | 1346 | 27.265 |
11:18 ET | 11146 | 27.24 |
11:20 ET | 2100 | 27.255 |
11:22 ET | 2563 | 27.28 |
11:24 ET | 5597 | 27.28 |
11:26 ET | 3636 | 27.32 |
11:27 ET | 3560 | 27.325 |
11:29 ET | 3318 | 27.295 |
11:31 ET | 2900 | 27.33 |
11:33 ET | 3316 | 27.315 |
11:36 ET | 2000 | 27.305 |
11:38 ET | 600 | 27.31 |
11:40 ET | 875 | 27.305 |
11:42 ET | 5974 | 27.295 |
11:44 ET | 1871 | 27.285 |
11:45 ET | 2038 | 27.29 |
11:47 ET | 7030 | 27.295 |
11:49 ET | 2000 | 27.3 |
11:51 ET | 2361 | 27.3 |
11:54 ET | 100 | 27.305 |
11:56 ET | 1305 | 27.305 |
11:58 ET | 6728 | 27.27 |
12:00 ET | 650 | 27.27 |
12:02 ET | 2394 | 27.265 |
12:03 ET | 7942 | 27.27 |
12:05 ET | 2164 | 27.275 |
12:07 ET | 2278 | 27.285 |
12:09 ET | 861 | 27.29 |
12:12 ET | 5260 | 27.265 |
12:14 ET | 945 | 27.275 |
12:16 ET | 3892 | 27.265 |
12:18 ET | 1845 | 27.26 |
12:20 ET | 600 | 27.255 |
12:21 ET | 600 | 27.255 |
12:23 ET | 11653 | 27.225 |
12:25 ET | 3972 | 27.25 |
12:27 ET | 766 | 27.255 |
12:30 ET | 10169 | 27.255 |
12:32 ET | 5589 | 27.245 |
12:34 ET | 4322 | 27.235 |
12:36 ET | 6518 | 27.25 |
12:38 ET | 500 | 27.255 |
12:39 ET | 1757 | 27.255 |
12:41 ET | 7548 | 27.24 |
12:43 ET | 3190 | 27.2 |
12:45 ET | 3372 | 27.21 |
12:48 ET | 792 | 27.205 |
12:50 ET | 1901 | 27.185 |
12:52 ET | 1350 | 27.195 |
12:54 ET | 1400 | 27.181 |
12:56 ET | 3545 | 27.185 |
12:57 ET | 371 | 27.19 |
12:59 ET | 1374 | 27.185 |
01:01 ET | 4735 | 27.155 |
01:03 ET | 3327 | 27.1747 |
01:06 ET | 6348 | 27.195 |
01:08 ET | 2000 | 27.205 |
01:10 ET | 2800 | 27.18 |
01:12 ET | 2529 | 27.1808 |
01:14 ET | 3646 | 27.175 |
01:15 ET | 753 | 27.175 |
01:17 ET | 1783 | 27.17 |
01:19 ET | 1925 | 27.17 |
01:21 ET | 4130 | 27.17 |
01:24 ET | 5078 | 27.18 |
01:26 ET | 2400 | 27.185 |
01:28 ET | 1247 | 27.2 |
01:30 ET | 5173 | 27.2 |
01:32 ET | 1231 | 27.193 |
01:33 ET | 576 | 27.195 |
01:35 ET | 3500 | 27.185 |
01:37 ET | 2170 | 27.195 |
01:39 ET | 6362 | 27.2098 |
01:42 ET | 700 | 27.21 |
01:44 ET | 1475 | 27.2001 |
01:46 ET | 10267 | 27.21 |
01:48 ET | 1795 | 27.205 |
01:50 ET | 4057 | 27.215 |
01:51 ET | 1325 | 27.215 |
01:53 ET | 2869 | 27.2053 |
01:55 ET | 3184 | 27.18 |
01:57 ET | 3407 | 27.17 |
02:00 ET | 5730 | 27.18 |
02:02 ET | 1600 | 27.155 |
02:04 ET | 1753 | 27.165 |
02:06 ET | 6719 | 27.14 |
02:08 ET | 5047 | 27.11 |
02:09 ET | 1820 | 27.1 |
02:11 ET | 5835 | 27.1 |
02:13 ET | 4714 | 27.115 |
02:15 ET | 426 | 27.115 |
02:18 ET | 1936 | 27.115 |
02:20 ET | 5055 | 27.115 |
02:22 ET | 1424 | 27.115 |
02:24 ET | 1675 | 27.11 |
02:26 ET | 2797 | 27.11 |
02:27 ET | 800 | 27.11 |
02:29 ET | 12817 | 27.145 |
02:31 ET | 3980 | 27.155 |
02:33 ET | 13658 | 27.1607 |
02:36 ET | 9817 | 27.16 |
02:38 ET | 4774 | 27.17 |
02:40 ET | 1135 | 27.175 |
02:42 ET | 5496 | 27.17 |
02:44 ET | 3629 | 27.16 |
02:45 ET | 9935 | 27.165 |
02:47 ET | 7165 | 27.185 |
02:49 ET | 600 | 27.18 |
02:51 ET | 5545 | 27.19 |
02:54 ET | 8835 | 27.19 |
02:56 ET | 5420 | 27.205 |
02:58 ET | 5726 | 27.205 |
03:00 ET | 4090 | 27.165 |
03:02 ET | 4351 | 27.16 |
03:03 ET | 1885 | 27.15 |
03:05 ET | 6136 | 27.155 |
03:07 ET | 3043 | 27.14 |
03:09 ET | 3555 | 27.14 |
03:12 ET | 7436 | 27.105 |
03:14 ET | 6395 | 27.12 |
03:16 ET | 1655 | 27.115 |
03:18 ET | 3480 | 27.09 |
03:20 ET | 7164 | 27.125 |
03:21 ET | 3713 | 27.095 |
03:23 ET | 2449 | 27.095 |
03:25 ET | 9258 | 27.12 |
03:27 ET | 7855 | 27.115 |
03:30 ET | 4092 | 27.125 |
03:32 ET | 6720 | 27.105 |
03:34 ET | 4617 | 27.13 |
03:36 ET | 6920 | 27.12 |
03:38 ET | 6733 | 27.155 |
03:39 ET | 4824 | 27.14 |
03:41 ET | 8495 | 27.165 |
03:43 ET | 5842 | 27.155 |
03:45 ET | 11118 | 27.16 |
03:48 ET | 7412 | 27.155 |
03:50 ET | 14009 | 27.155 |
03:52 ET | 26460 | 27.085 |
03:54 ET | 32941 | 27.125 |
03:56 ET | 28394 | 27.105 |
03:57 ET | 46957 | 27.085 |
03:59 ET | 338181 | 27.09 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Royalty Pharma PLC | 16.4B | 15.2x | +1.83% |
Amneal Pharmaceuticals Inc | 2.1B | -11.9x | --- |
Catalent Inc | 9.7B | -8.7x | --- |
Jazz Pharmaceuticals PLC | 6.6B | 21.9x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Prestige Consumer Healthcare Inc | 3.2B | 15.5x | --- |
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.4B |
---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 597.4M |
Dividend Yield | 3.10% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.47 |
EPS | $1.78 |
Book Value | $14.61 |
P/E Ratio | 15.2x |
Price/Sales (TTM) | 7.3 |
Price/Cash Flow (TTM) | 13.7x |
Operating Margin | 41.96% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.